Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
BMRN > SEC Filings for BMRN > Form 8-K on 28-Nov-2012All Recent SEC Filings

Show all filings for BIOMARIN PHARMACEUTICAL INC

Form 8-K for BIOMARIN PHARMACEUTICAL INC


28-Nov-2012

Change in Directors or Principal Officers


Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On November 26, 2012, the Compensation Committee of the Board of Directors (the "Compensation Committee") of BioMarin Pharmaceutical Inc. (the "Company") approved an additional cash bonus of $50,000 (to be paid immediately) for Robert
A. Baffi, Ph.D., the Company's Executive Vice President, Technical Operations, and an additional cash bonus of $100,000 (to be paid immediately) for Henry J. Fuchs, M.D., Ph.D., the Company's Executive Vice President, Chief Medical Officer. The Compensation Committee awarded Dr. Baffi and Dr. Fuchs these additional bonuses to reward them for their extraordinary efforts in connection with the Company's pivotal Phase 3 study of GALNS for the treatment of patients with the rare lysosomal storage disorder Mucopolysaccharidosis Type IVA (MPS IVA).

- 2 -


  Add BMRN to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for BMRN - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.